Monique Coney

Monique Coney serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, diagnostic, and operational capabilities. She manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research tools, and data infrastructure critical to disease surveillance and outbreak response. Her work ensures timely access to high-integrity technical solutions that enable CDC’s scientific workforce to detect, analyze, and mitigate emerging health threats across the nation. Coney maintains strong working relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, reflecting a preference for established industry partners with proven expertise in advanced diagnostics, biological product development, and high-throughput analytical systems. Her procurement patterns emphasize long-term vendor partnerships grounded in technical reliability and regulatory compliance, particularly in areas requiring FDA-regulated or CLIA-certified capabilities. She frequently collaborates with contractors capable of delivering integrated laboratory solutions, genomic sequencing platforms, and data processing systems aligned with federal public health standards. Her contracting activity reflects a strong emphasis on open competition, with 88.2% of awards issued without set-aside designations, indicating a focus on technical merit and mission-critical performance over socioeconomic preferences. However, she consistently supports small business participation through Total Small Business Set-Asides under FAR 19.5, demonstrating a balanced approach that prioritizes capability while fostering innovation from smaller, agile vendors. Coney’s procurement focus centers on NAICS 334516 (analytical laboratory instrumentation), 541990 (professional scientific services), and 325414 (biological product manufacturing), underscoring deep expertise in procuring diagnostic equipment, clinical research services, and biosafety-compliant biological materials. Her domain knowledge spans infectious disease detection technologies, real-time data analytics platforms, and laboratory automation systems essential to CDC’s operational readiness and scientific leadership.